James Hall - Jun 1, 2023 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Executive Officer, Director
Signature
/s/ Rebecca Hilt, Attorney-In-Fact for James Hall
Stock symbol
LFCR
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 03:27 PM
Previous filing
Aug 15, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +150K +293.57% 201K Jun 1, 2023 Direct F1, F2
transaction LFCR Common Stock Award +75K +37.3% 276K Jun 1, 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Restricted Stock Units will vest on the 3rd anniversary of the grant date.
F3 Restricted Stock Units will vest on the 3rd anniversary of the grant date or if earlier, upon a Change in Control.